The potential role of PKC beta in diabetic retinopathy and macular edema.
about
Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathyPresence and Risk Factors for Glaucoma in Patients with Diabetes.Medical management of diabetic retinopathy.Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory responseEmerging drugs for diabetic retinopathy.Diabetic retinopathy: current management and experimental therapeutic targets.Novel Pharmacologic Approaches for the Management of Diabetic RetinopathyAntiangiogenic therapy for ischemic retinopathies.Correlation between diabetic lower-extremity arterial disease and diabetic neuropathy in patients with type II diabetes: an exploratory study.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Interocular symmetry of abnormal multifocal electroretinograms in adolescents with diabetes and no retinopathyPharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.Pathomechanisms of cystoid macular edema.Pathogenesis and classification of proliferative diabetic vitreoretinopathy.Protein kinase C subtypes and retinal ischemic preconditioningCurrent and future approaches in the prevention and treatment of diabetic retinopathy.PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice.Ruboxistaurin: PKC-beta inhibition for complications of diabetes.The renal effects of blood glucose-lowering plant-derived extracts in diabetes mellitus--an overview.Protein kinase C βII in diabetic complications: survey of structural, biological and computational studies.EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.Protein kinase C-mediated regulation of matrix metalloproteinase and tissue inhibitor of metalloproteinase production in a human retinal müller cells.IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels.Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema.Computational investigation of pkcβ inhibitors for the treatment of diabetic retinopathy.Protein kinase C activation affects, via the mRNA-binding Hu-antigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model.Protein kinase C in porcine retinal arteries and neuroretina following retinal ischemia-reperfusion.Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.Intravitreal bevacizumab (Avastin) for primary treatment of diabetic macular oedema.The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy.Effects of Trigonella foenum-graecum (L.) on retinal oxidative stress, and proinflammatory and angiogenic molecular biomarkers in streptozotocin-induced diabetic rats.Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin.Emerging pharmacotherapies for diabetic macular edema
P2860
Q27021701-06618689-C3BA-466A-A4C0-392DA0A5B108Q30244246-1315F6C1-59C9-429B-A34D-B0014CA0DB45Q33204062-934168F5-C066-4443-AE9E-FEC8AE7D731AQ33325652-3DE5A832-8E1F-4AC2-8131-0CA31EB147CFQ33343728-A908319D-0B2E-4F45-85C4-5A405C572538Q33388498-43AD67CA-E6C9-4372-91D5-32B374F78DE1Q33403016-D6814F0B-1F0A-4FAB-BF07-050AA9B2032FQ33751308-7CE3215D-B7EB-4826-B8B3-B8547CEE8CA7Q34295974-69EB106D-C85E-49F0-A1C8-694E27FF165BQ35173922-B8A6FE63-2F44-4BB9-92FC-C8D0CC9F3C39Q35770186-B5EC2B96-305A-4412-B747-377657A80B7AQ35797240-389B2922-DDA6-4425-B87A-F35DADF81C8AQ35827367-37C57730-0041-470E-A049-CFE24EAED2DBQ35975532-65EEEA56-0DD5-423C-937C-E2E953BE2063Q36767464-7B1B6EA9-6BFF-4AE9-A2B8-17DD3034DB35Q37014810-7B14D96D-D23E-40F1-90FD-19A1BB62312AQ37221516-EACBCB0E-9FD3-4861-967D-F01EEB7C8AB1Q37397476-FDFC85C5-46C2-477D-9CC0-2584170A1310Q37636163-CE3FBBE2-7073-41D6-9F28-A06BFE7C2C47Q37683784-3AD38C37-608F-44E0-AB38-5C3F25951586Q37992101-18F029A2-0297-42BD-9B31-0F319254400BQ38404246-D53333FB-D1A7-45A9-9F28-7D343FDFC45DQ38620860-3EFB17EE-8F12-451E-9206-A28A003EF07EQ38719213-CEEB8E5E-81B8-41C9-8373-C0B6C04C4738Q39336760-5D264DCF-52D1-439C-8B1E-A4269AC2CDA1Q41066130-48327147-D1B1-4C42-85EB-6DA4CBD7026CQ41545792-3926121F-C09C-416E-A879-AC84F79409E2Q41906754-9D1C4381-5855-4F95-8696-080F808AA33EQ42268509-FFE7CB25-736D-49A1-A133-92A25FCFA7D6Q43146010-FE0BA8BD-A33F-41F4-9249-813A086355B3Q45264621-E3FFFF4C-C6F3-47C6-B536-82B481067FCAQ46626407-66205A43-B407-47CB-B31B-8CB3EB56FBC7Q48308877-2243362B-4736-4E77-AF46-E4C77E09E932Q53490476-332FCB6E-355B-4EA0-A69D-9562ED757426Q54396384-80C9A2CA-D95D-4914-88BA-B18711FAC23DQ54405122-6A1A5B17-E420-4B28-B7D0-C73B2845D27EQ58907881-BB2B5699-0C21-4E11-AA08-222E58A7BFA6
P2860
The potential role of PKC beta in diabetic retinopathy and macular edema.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The potential role of PKC beta in diabetic retinopathy and macular edema.
@ast
The potential role of PKC beta in diabetic retinopathy and macular edema.
@en
type
label
The potential role of PKC beta in diabetic retinopathy and macular edema.
@ast
The potential role of PKC beta in diabetic retinopathy and macular edema.
@en
prefLabel
The potential role of PKC beta in diabetic retinopathy and macular edema.
@ast
The potential role of PKC beta in diabetic retinopathy and macular edema.
@en
P1476
The potential role of PKC beta in diabetic retinopathy and macular edema.
@en
P2093
Lloyd Paul Aiello
P304
P356
10.1016/S0039-6257(02)00391-0
P478
47 Suppl 2
P577
2002-12-01T00:00:00Z